Lisdexamfetamine Dimesylate
NDC 60505-4739, Lisdexamfetamine Dimesylate, capsule, from Apotex Corp..
- Product NDC
- 60505-4739
- Status
- Listed
- Labeler
- Apotex Corp.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216944
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/60505-4739 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISDEXAMFETAMINE DIMESYLATE10 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60505-4739-1 | 60505473901 | 100 CAPSULE in 1 BOTTLE (60505-4739-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ecad4442-a644-18e3-6ff2-fdbac45eec47NADAC price for package 60505473901
GET /v1/drugs/nadac/60505473901
Use it
Look up 60505-4739 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60505-4739 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60505-4739. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.